Cannabis

Canopy Rivers Portfolio Company Receives Approval to Research UV Light Impact on Cannabis Plant

BioLumic partners with JWC and Helius Therapeutics for cannabis research program TORONTO, Jan. 9, 2020 /PRNewswire/ -- Canopy Rivers Inc. ("Canopy Rivers") (TSX: RIV, OTC: CNPOF) portfolio company BioLumic Ltd. ("BioLumic") has received approval from the New Zealand Ministry of Health to apply it...

2020-01-08 20:00 6215

PathogenDx Lauded by Frost & Sullivan for Its Game-changing DNA-based Multiplex Microarray Technology

PathogenDx's breakthrough technology shifts the pathogen detection paradigm from microbial to molecular testing through its microarray assays, namely Detect X, EnviroX, and QuantX SANTA CLARA, California, Dec. 3, 2019 /PRNewswire/ -- Based on its recent analysis of the global microbial DNA testin...

2019-12-03 22:00 1391

Canopy Growth Corporation Receives Major Project Status From The Australian Government

SMITHS FALLS, Ontario, December 3, 2019 /PRNewswire/ -- Canopy Growth Corporation, ("Canopy Growth"), with its medical division Spectrum Therapeutics, is pleased to announce that it's application for Major Project Status (MPS) has been granted by the Australian Federal Governments Department of ...

2019-12-03 11:42 1539

Spectrum Therapeutics Partners with Emerald Clinics on Real World Evidence Research

VICTORIA, Australia, Nov. 11, 2019 /PRNewswire/ -- Spectrum Therapeutics ("Spectrum"), the medical division of Canopy Growth Corporation (Canopy Growth), is pleased to announce an Australian first for the company. Spectrum has partnered with Emerald Clinics Australia (Emerald Clinics) to collect ...

2019-11-11 05:00 1506
12